Saliladja, Jay W.
HRN: 25-51-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/17/2024
07/24/2024
IV INFUSION
4.5GM
Q8H
SEPTIC SHOCK PROB SEC TO RUPTURED TOPHI
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes